-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
THC Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- THC Therapeutics, Inc. Operating Income (Loss) for the quarter ending January 31, 2024 was -$85.2K, a 68.9% increase year-over-year.
- THC Therapeutics, Inc. Operating Income (Loss) for the twelve months ending January 31, 2024 was -$253K, a 75.6% increase year-over-year.
- THC Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$494K, a 71.7% increase from 2022.
- THC Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.75M, a 85.8% decline from 2021.
- THC Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$940K, a 32.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)